mitiglinide has been researched along with Alloxan Diabetes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Ojima, K; Takeda, H; Tatemichi, S; Yokoyama, A | 1 |
| Akahane, K; Imai, Y; Inoue, T; Kiguchi, S; Ojima, K; Takeda, H; Tatemichi, S; Yokoyama, A | 1 |
| Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Maruyama, K; Mori, Y; Ojima, K; Yaguchi, A; Yokoyama, A | 1 |
| Cai, S; Huo, T; Li, F; Lu, X; Xu, J; Zheng, S | 1 |
| Kusama, H; Shibata, N | 1 |
| Cerasi, E; Efendic, S; Kaiser, N; Nesher, R; Oprescu, A | 1 |
| Kikuta, T; Nagamatsu, S; Nakamichi, Y; Nishiwaki, C; Ohara-Imaizumi, M | 1 |
| Kobayashi, M; Koizumi, T; Momose, Y; Ohnota, H; Sato, F | 1 |
| Hamano, S; Kinukawa, M; Kitamura, T; Miyata, H; Ohnota, H; Shibata, N; Ujiie, A | 1 |
| Hamano, S; Ichikawa, K; Kitamura, T; Komatsu, H; Misawa, K; Ojima, K | 1 |
1 review(s) available for mitiglinide and Alloxan Diabetes
| Article | Year |
|---|---|
[Mitiglinide (KAD-1229)].
Topics: Animals; ATP-Binding Cassette Transporters; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2002 |
9 other study(ies) available for mitiglinide and Alloxan Diabetes
| Article | Year |
|---|---|
Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Glucose Tolerance Test; Glyburide; Isoindoles; Male; Rats; Sitagliptin Phosphate | 2017 |
Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Isoindoles; Male; Obesity; Rats, Sprague-Dawley; Rats, Zucker | 2017 |
Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Isoindoles; Niacinamide; Rats; Rats, Zucker; Streptozocin | 2015 |
Effect of mitiglinide on Streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study based on ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Isoindoles; Male; Metabolomics; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2009 |
Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.
Topics: Animals; Arginine; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Gerbillinae; Glucose; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Insulin-Secreting Cells; Isoindoles; Perfusion; Rats; Rats, Wistar | 2005 |
Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules.
Topics: Animals; ATP-Binding Cassette Transporters; Diabetes Mellitus, Experimental; Glyburide; Hypoglycemic Agents; Image Processing, Computer-Assisted; Indoles; Insulin; Insulin-Secreting Cells; Isoindoles; Male; Membrane Fusion; Mice; Mice, Knockout; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Potassium Channels, Inwardly Rectifying; Rats; Rats, Mutant Strains; Rats, Wistar; Receptors, Drug; Sulfonylurea Receptors | 2006 |
Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus rats.
Topics: Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus, Experimental; Food; Gliclazide; Glucose Tolerance Test; Hypoglycemic Agents; Immunohistochemistry; Indoles; Isoindoles; Pancreas; Rats; Rats, Sprague-Dawley | 1995 |
A rapid- and short-acting hypoglycemic agent KAD-1229 improves post-prandial hyperglycemia and diabetic complications in streptozotocin-induced non-insulin-dependent diabetes mellitus rats.
Topics: Albuminuria; Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Isoindoles; Male; Pancreas; Rats; Rats, Sprague-Dawley; Streptozocin | 1996 |
Effect of KAD-1229, a nonsulfonylurea hypoglycemic agent, on plasma glucose and insulin in streptozotocin-induced diabetic dogs.
Topics: Animals; Anti-Bacterial Agents; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dogs; Gliclazide; Glucose Tolerance Test; Hypoglycemic Agents; Indoles; Insulin; Isoindoles; Male; Streptozocin | 2001 |